Business The Good Shroom Co reports 600% year-over-year revenue growth Revenue mushrooming was attributed to the company's cannabis operations and functional fungi drinks Rowan DunneNovember 24, 2022
Cannabis U.S. senators introduce bill to improve access to psilocybin and MDMA The bill would reduce 'unreasonably burdensome rules and regulations' Rowan DunneNovember 23, 2022
Canada Filament Health to supply psilocybin for federally-funded psychedelics clinical trial The trial is the first psilocybin study funded by the Canadian Institutes of Health Research (CIHR) Natalia Buendia CalvilloNovember 17, 2022
Canada PharmAla and Mindset enter psilocybin distribution agreement PharmAla will have exclusive rights to resell Mindset's cGMP psilocybin to designated researchers Rowan DunneNovember 16, 2022
Psychedelics TripSitter acquires Reconscious Medical assets to enhance its treatment options TripSitter says the acquisition will be 'instrumental' for the future of the company Rowan DunneNovember 14, 2022
Canada PsyCan aims to be ‘go-to’ psychedelics industry organization, receives support from lawmakers The non-profit trade association received a high level of interest from multiple branches of government Rowan DunneNovember 10, 2022
Canada UBC psychedelics conference attracts multidisciplinary crowd with a shared passion From psilocybin mushroom cultivators to artists and Indigenous leaders, the conference united a broad range of people Rowan DunneNovember 8, 2022
Canada Apex gets Health Canada approval for Veterans take-home psilocybin drug trial Trial will evaluate the efficacy of synthetic psilocybin drug 'APEX-52' for treating vets with PTSD Rowan DunneNovember 4, 2022
International Enosis and OVID Clinics offer VR-modulated psychedelic therapy in Berlin The companies say this will be the 'world's first' in-clinic application of VR with psychedelic-assisted therapy Rowan DunneNovember 3, 2022
Psychedelics Small Pharma gets approval for upcoming injectable DMT trial on humans New phase I study will be held at MAC Clinical Research in Manchester, England next year Rowan DunneOctober 31, 2022